| RS1361332747 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1361356353 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1361370524 |
B4GALNT1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1361382376 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS1361393564 |
IFT81
|
Health Risk |
Pathogenic |
— |
| RS1361408137 |
NCSTN
|
Health Risk |
Likely pathogenic |
— |
| RS1361420677 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Inborn genetic diseases |
| RS1361427704 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1361442490 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1361450354 |
SGCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1361451153 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS1361454479 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1361458223 |
AARS1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1361462274 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1361495767 |
PIGQ
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 77 |
| RS1361496246 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1361499651 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Polycystic kidney disease |
| RS1361512116 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1361526419 |
SLC3A1
|
Health Risk |
Pathogenic |
Cystine urolithiasis, Cystinuria |
| RS1361547443 |
PGAP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 42 |
| RS1361564558 |
ZNF469
|
Health Risk |
Likely pathogenic |
— |
| RS1361564818 |
ECEL1
|
Health Risk |
Pathogenic |
Distal arthrogryposis type 5D, Distal arthrogryposis type 5D |
| RS1361568839 |
LTBP4
|
Health Risk |
Pathogenic |
— |
| RS1361624164 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS1361625543 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS1361659361 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, CASK-related |
| RS1361667907 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1361669364 |
ZC4H2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1361687182 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis, Familial hemophagocytic lymphohistiocytosis 2 |
| RS1361693785 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS1361710673 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS1361715855 |
WDR62
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1361730422 |
CREB3L1
|
Health Risk |
Pathogenic |
— |
| RS1361739260 |
RPL11
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 7 |
| RS1361739547 |
PREPL
|
Health Risk |
Pathogenic |
Myasthenic syndrome, congenital |
| RS1361753522 |
NIPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 6, Hereditary spastic paraplegia 6 |
| RS1361763237 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1361772036 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, FKTN-related disorder |
| RS1361784389 |
NPRL3
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS1361816581 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1361858388 |
KCNJ13
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 16, Retinitis pigmentosa |
| RS1361885101 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1361897950 |
CANT1
|
Health Risk |
Likely pathogenic |
Joint dislocation, Short stature |
| RS1361910224 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1361922924 |
RASA1
|
Health Risk |
Pathogenic |
— |
| RS1361922961 |
C1QB
|
Health Risk |
Pathogenic |
C1Q deficiency 2, C1Q deficiency 2 |
| RS1361923069 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1361925574 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1361929051 |
LIPE
|
Health Risk |
Likely pathogenic |
LIPE-related familial partial lipodystrophy, LIPE-related familial partial lipodystrophy |
| RS1361931808 |
CP
|
Health Risk |
Likely pathogenic |
CP-related disorder, CP-related disorder |
| RS1361964123 |
EXOSC9
|
Health Risk |
Likely pathogenic |
— |
| RS1361986900 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1361993950 |
CKAP2L
|
Health Risk |
Pathogenic |
Filippi syndrome, Filippi syndrome |
| RS1361998528 |
HEXB
|
Health Risk |
Pathogenic/Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS1361999742 |
ASL
|
Health Risk |
Conflicting classifications of pathogenicity |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1362008756 |
TBCD
|
Health Risk |
Likely pathogenic |
— |
| RS1362009010 |
SPINK5
|
Health Risk |
Pathogenic |
Ichthyosis linearis circumflexa, Ichthyosis linearis circumflexa |
| RS1362013257 |
KCNJ16
|
Health Risk |
Pathogenic |
Hypokalemic tubulopathy and deafness, Hypokalemic tubulopathy and deafness |
| RS1362046514 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS1362058277 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS1362058696 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Retinitis pigmentosa 39 |
| RS1362074591 |
TUBGCP6
|
Health Risk |
Likely pathogenic |
— |
| RS1362078144 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS1362123883 |
GALK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1362124228 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1362154291 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1362164894 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1362178149 |
SETX
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1362191804 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1362195093 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1362202777 |
LIAS
|
Health Risk |
Likely pathogenic |
— |
| RS1362220560 |
SERPING1
|
Health Risk |
Likely pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS1362224320 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1362231306 |
EPM2A
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS1362231446 |
ORC1
|
Health Risk |
Likely pathogenic |
— |
| RS1362283507 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1362305882 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1362306576 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor H deficiency, Chronic kidney disease |
| RS1362309822 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Transient bullous dermolysis of the newborn, Recessive dystrophic epidermolysis bullosa |
| RS1362318397 |
CNGA3
|
Health Risk |
Pathogenic |
— |
| RS1362318488 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory and autonomic |
| RS1362343873 |
PLOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS1362347834 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1362360030 |
COL2A1
|
Health Risk |
Pathogenic |
15 conditions, Inborn genetic diseases |
| RS1362360554 |
GYS1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS1362374699 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1362409861 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Cardiovascular phenotype |
| RS1362460137 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
8 conditions, Frasier syndrome |
| RS1362463869 |
MOCOS
|
Health Risk |
Likely pathogenic |
Xanthinuria type II, Xanthinuria type II |
| RS1362472371 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1362475419 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS1362511475 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1362518517 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1362520746 |
NHLRC1
|
Health Risk |
Pathogenic |
Lafora disease, Lafora disease |
| RS1362524399 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1362530862 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS1362562605 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Jeune thoracic dystrophy |
| RS1362564667 |
NEK9
|
Health Risk |
Likely pathogenic |
Arthrogryposis, Perthes disease |
| RS1362570122 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS1362575880 |
PSEN1
|
Health Risk |
Likely pathogenic |
Acne inversa, familial |